PROBUPHINE Trademark

Trademark Overview

On Monday, August 4, 2014, a trademark application was filed for PROBUPHINE with the United States Patent and Trademark Office. The USPTO has given the PROBUPHINE trademark a serial number of 86356901. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 13, 2023. This trademark is owned by Titan Pharmaceuticals, Inc.. The PROBUPHINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of pain management
probuphine

General Information

Serial Number86356901
Word MarkPROBUPHINE
Filing DateMonday, August 4, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 13, 2023
Registration Number5171923
Registration DateTuesday, March 28, 2017
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 9, 2014

Trademark Statements

Description of MarkThe mark consists of the word "PROBUPHINE", and the "I" in "PROBUPHINE" has four diagonal lines above it.
Goods and ServicesPharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of pain management
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 13, 2023
Primary Code005
First Use Anywhere DateFriday, June 10, 2016
First Use In Commerce DateFriday, June 10, 2016

Trademark Owner History

Party NameTitan Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameTitan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameTitan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, January 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, January 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 13, 2023CANCELLED SEC. 8 (6-YR)
Monday, March 28, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, December 26, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 26, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 28, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, February 21, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, February 19, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 6, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 13, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 13, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 30, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 30, 2016NON-FINAL ACTION E-MAILED
Tuesday, August 30, 2016SU - NON-FINAL ACTION - WRITTEN
Saturday, August 13, 2016STATEMENT OF USE PROCESSING COMPLETE
Friday, July 22, 2016USE AMENDMENT FILED
Friday, July 22, 2016TEAS STATEMENT OF USE RECEIVED
Wednesday, March 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 8, 2016SOU EXTENSION 2 GRANTED
Wednesday, February 3, 2016SOU EXTENSION 2 FILED
Monday, March 7, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 3, 2016SOU TEAS EXTENSION RECEIVED
Friday, July 31, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 29, 2015SOU EXTENSION 1 GRANTED
Wednesday, July 29, 2015SOU EXTENSION 1 FILED
Wednesday, July 29, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, February 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 9, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 9, 2014PUBLISHED FOR OPPOSITION
Wednesday, November 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 1, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 31, 2014ASSIGNED TO LIE
Wednesday, October 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 15, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 14, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 14, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 24, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 24, 2014NON-FINAL ACTION E-MAILED
Wednesday, September 24, 2014NON-FINAL ACTION WRITTEN
Tuesday, September 23, 2014ASSIGNED TO EXAMINER
Wednesday, August 13, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, August 12, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 7, 2014NEW APPLICATION ENTERED

Related Keywords

probuphine sustained formulation matrix release drugs management pain treatment subdermal based